ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PRM Proteome Sciences Plc

4.15
0.64 (18.23%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.64 18.23% 4.15 3.50 4.80 - 423,867 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 7.78M 1.33M 0.0045 7.80 10.36M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 3.51p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.97p to 8.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £10.36 million. Proteome Sciences has a price to earnings ratio (PE ratio) of 7.80.

Proteome Sciences Share Discussion Threads

Showing 157101 to 157115 of 157525 messages
Chat Pages: Latest  6289  6288  6287  6286  6285  6284  6283  6282  6281  6280  6279  6278  Older
DateSubjectAuthorDiscuss
12/1/2024
11:09
Welcome ;-)
peverill
12/1/2024
10:54
Yes education doesn't always mean you have life skills,manners and a bit of humility or spend your life defending sheister CEO's.As for judge of character CJP,Harry Adam's,don't make me laugh,one and the same.
peverill
12/1/2024
10:47
I am still 'banged up' in isolation by Goatherd, a whole life sentence it would seem.
dominiccummings
12/1/2024
10:46
Monte,

Actually you have no idea as to my stock picking ability.

For the ones I post about, perhaps you have a point (though time will tell). But much of my investment is through programmed selection. And I never post anything about that. Much of it is making around 60% per year - which I think is acceptable. But it is rather boring, so I do not talk about it.

goatherd
12/1/2024
09:00
92620

No, I left school at 16.

I've never lost a penny piece on this POS though or indeed any of the other bombed out money pits that you are so attracted to, if that counts for anything at all?

james japp
12/1/2024
08:57
You are also, quite probably, the most pompous avatar ever to (dis)grace the freebb, totally lacking in self awareness and a massive bellend to boot. Oh, and quite possibly the world’s worst stock picker.

aimho, dyor, nag.

monte1
12/1/2024
06:09
Isn't the company an abject failure? May I add the company is run by a Billy Liar of a man.
canaletto
12/1/2024
06:08
Why on earth ban PevIsn't what he has written true?
canaletto
10/1/2024
18:39
Thanks Monte,much appreciated ;-).
peverill
10/1/2024
14:45
You can also see why that was a pointless exercise.
monte1
10/1/2024
11:22
Then there's the Mad Deer Disease ...
small crow
10/1/2024
10:26
Go on, then (2)
jeffian
10/1/2024
10:23
wasjobber,

I agree, 32-plex TMT Pro will provide a big increase to the revenue figures. But I've just received information from someone I trust impeccably that the Randox Stroke test will definitely be released during the course of this year.

Now that will really put a rocket under the revenue figures.

pools2
10/1/2024
10:15
Given the history and the timespan over which many have held, it may be that the market is waiting to see "earning potential" turn into "earning". Show us the money!

"its will also provide a dramatic increase in revenues". Go on, then.

jeffian
10/1/2024
09:54
I'm not sure many people have understood the implications of Proteome Sciences now using their 32-plex TMTpro reagents in their biomarker services business. Quite simply it immediately almost doubles the sampling capacity and revenue earning potential of their current laboratory services business. Proteome Sciences have said that they'll soon be signing much bigger biomarker services contracts.

Also, when Thermo Scientific release the commercial 32-plex TMTpro reagents in a few months, its will also provide a dramatic increase in revenues.

STRONG BUY

wasjobber
Chat Pages: Latest  6289  6288  6287  6286  6285  6284  6283  6282  6281  6280  6279  6278  Older

Your Recent History

Delayed Upgrade Clock